Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes

Clinical Infectious Diseases

Volumn 46, Issue 8, 2008, Pages 1323-1324

  Lee, Nelson ^a,b   Cockram, C S ^a   Chan, P K S ^a   Hui, D S C ^a   Choi, K W ^a   Sung, J J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; OSELTAMIVIR;

CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; FISHER EXACT TEST; HOSPITALIZATION; HUMAN; INFLUENZA; INTERVENTION STUDY; LETTER; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; STUDENT T TEST; TREATMENT OUTCOME; VIRUS LOAD;

ANTIVIRAL AGENTS; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; TREATMENT OUTCOME;

EID: 42549121263     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/533477     Document Type: Letter

References (5)

1. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:1568-75.
2. Lee N, Chan PKS, Choi KW, et al. Factors associated with early hospital discharge of adult influenza patients. Antiviral Therapy 2007; 12: 501-8.
3. Ong AK, Hayden FG. John F. Enders Lecture 2006: antivirals for influenza. J Infect Dis 2007; 196:181-90.
4. Crusat M, de Jong MD. Neuraminidase inhibitors and their role in avian and pandemic influenza. Antiviral Therapy 2007; 12:593-602.
5. Lee N, Wong CK, Chan PKS, et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A infections. Clin Infect Dis 2007; 45:723-31.